Fractyl Health, Inc. (GUTS)
Healthcare
- Fundamental
- 1
- Sentiment
- 1
- Technical
- 2
Do Nothing: 15 core indicators failed to load and the technical read is unreliable; upstream fundamentalScore 1 and qualitativeScore 1 are also below the required floor of 3.
Company overview
Fractyl Health, Inc. is a metabolic therapeutics company focused on developing treatments for type 2 diabetes and obesity. Its key products include the Revita DMR System, a procedural therapy targeting duodenal dysfunction, and Rejuva, a gene therapy platform aimed at altering metabolic hormone function. The company was founded in 2010 and is based in Burlington, Massachusetts.
Fundamental
very weakFractyl Health's fundamentals are speculative, with going-concern language and reliance on financing.
Clinical-stage biotech with minimal revenue, heavy cash burn, and explicit going‑concern language in recent SEC filings. While liquidity is adequate on a headline current-ratio basis, the business depends on additional financing (dilution risk) and also faces Nasdaq bid-price compliance risk. Insider buying is a positive, but overall fundamentals remain highly speculative.
Sentiment
very weakSentiment has cooled sharply, with no clear bullish catalysts in the near term.
Media is digesting the Q2 results/business update (announced 2026-08-10) and a subsequent downgrade, with last-14d coverage near-flat (polarity_score ≈ +0.07) after a strongly positive May–Jul baseline (≈ +0.47). Severe red-flag cap applied due to disclosed going-concern/substantial-doubt language, which keeps financing/dilution risk front-and-center for the next 1–30 trading days.
Technical
weakTechnical analysis is unreliable due to indicator suite failures.
Technical read is unreliable because the core TECHNICALMCP indicator suite failed to load (quote, trend, momentum, volatility, and chart endpoints all returned session errors). Intraday/event tools were run, but the mandatory indicator set could not be validated.
You’re looking at 2026-08-18 — more than 2 trading days ago.
Subscribers saw this then, and see today’s score, verdict and trade plan now.
More Healthcare
Not financial advice. For informational and educational purposes only.